Properties
Description
VZ185 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD7 and BRD9.
Molecular Formula
C53H67FN8O8S
Targets
BRD7: 4.5 nM (DC50); BRD9: 1.8 nM (DC50)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
VZ185 is utilized to explore the selective inhibition of BET bromodomains in cancer research.
